CRON Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Loading...
Cronos Group Inc (CRON) is not a strong buy at the moment for a beginner investor with a long-term focus. While the company has shown strong revenue growth and positive developments in its operations, the recent financial performance, including a net loss and declining EPS, combined with the lack of significant trading signals, suggests that the stock does not present an optimal entry point right now. For a long-term investor, it may be better to monitor the stock for further developments and improved financial stability.
The stock's technical indicators are mixed. The MACD is positive but contracting, suggesting weakening momentum. RSI is neutral at 48.592, indicating no clear overbought or oversold conditions. Moving averages are bullish (SMA_5 > SMA_20 > SMA_200), but the stock is trading below its pivot point of 2.664, with support at 2.572 and resistance at 2.755.
Strong revenue growth of 47% YoY in Q4
Positive analyst ratings with Buy recommendations and price targets of C$4.25 and C$4.
Expansion plans, including the acquisition of CanAdelaar, to strengthen its market position in Europe.
Net loss of $0.5 million in Q4 2025, driven by foreign exchange losses.
Declining EPS (-118.18% YoY) and negative net income (-104.15% YoY).
Regulatory pressures and market competition causing stock price declines.
In Q4 2025, Cronos Group reported revenue of $44.5 million, up 46.96% YoY, exceeding market expectations by $5.8 million. However, the company posted a net loss of $1.82 million, with EPS dropping to -0.02. Gross margin improved to 35.45%, up 3.87% YoY.
Analysts have initiated coverage with Buy ratings and price targets of C$4.25 and C$4.50, citing strong Canadian cannabis brands, profitability potential, and transformational growth opportunities in Europe.
